CURITY Pharma

Medical & Regulatory Disclaimer

CURITY PHARMA A.E.

MEDICAL & REGULATORY DISCLAIMER

Document ID: LEG-WEB-004
Version: 1.0
Effective Date: 06 July 2026
Review Date: 06 July 2028
Document Owner: Curity Pharma A.E.


1. Purpose of this Website

The Curity Pharma website is intended exclusively to provide general corporate, scientific and educational information relating to:

The information published on this website is intended for informational purposes only.


2. No Medical Advice

The content of this website does not constitute:

Visitors should not rely upon information contained on this website when making medical decisions.

Any person seeking medical advice should consult an appropriately qualified healthcare professional.

Healthcare professionals should consult the approved prescribing information and applicable regulatory documentation for any medicinal product.


3. No Promotion of Medicinal Products

Curity Pharma is committed to complying with all applicable legislation governing communications relating to medicinal products.

Nothing contained on this website shall be interpreted as:

Where medicinal cannabis is discussed, such references are intended solely to explain scientific, agricultural or pharmaceutical concepts.


4. Scientific Information

Scientific information presented on this website is provided exclusively for educational and informational purposes.

Scientific publications, references, literature reviews and research summaries should not be interpreted as:

Scientific knowledge continuously evolves.

Accordingly, information published on this website may change as new evidence becomes available.


5. Research and Development

Descriptions of research activities, cultivation methodologies, manufacturing technologies and scientific developments are provided to describe Curity Pharma’s areas of expertise and ongoing activities.

Unless expressly stated otherwise, such information does not constitute:


6. Regulatory Status

The regulatory status of medicinal cannabis and cannabis-derived medicinal products differs significantly between countries.

Information published on this website may not be applicable or authorised in every jurisdiction.

Visitors are responsible for ensuring compliance with the laws and regulations applicable in their own jurisdiction.

Nothing contained on this website should be interpreted as indicating that any product is authorised, marketed or available in every country.


7. Product Availability

Where products, formulations or technologies are mentioned, such references are intended solely to describe Curity Pharma’s scientific or business activities.

Reference to a product does not imply that it:

Availability remains subject to applicable legislation and regulatory approvals.


8. Genetics and Cultivars

Descriptions of cultivars, genetics, cannabinoid profiles, terpene profiles or cultivation characteristics are intended solely to describe botanical or scientific properties.

Such descriptions should not be interpreted as:

Agricultural and biological systems naturally exhibit variability despite rigorous quality systems.


9. Intellectual Property

Unless otherwise indicated, all scientific summaries, graphics, photographs, cultivation imagery, facility photographs, diagrams, technical illustrations and other proprietary content published on this website are the intellectual property of Curity Pharma A.E.

Scientific publications remain the property of their respective copyright holders.

Nothing contained on this website grants any licence or right to reproduce proprietary material without prior written permission.


10. Third-Party References

The website may contain references or links to:

Such references are provided solely for convenience and informational purposes.

Curity Pharma does not necessarily endorse the views expressed within third-party publications.


11. Limitation of Liability

To the fullest extent permitted by applicable law, Curity Pharma accepts no responsibility for decisions made solely on the basis of information published on this website.

Users remain responsible for obtaining independent professional advice where appropriate.


12. Changes to this Disclaimer

Curity Pharma may revise this Disclaimer from time to time to reflect:

The latest version will always be available on the website.


13. Contact

Questions regarding this Disclaimer may be directed to:

CURITY PHARMA A.E.

20 Chelmou Street
15125 Marousi
Athens
Greece

GEMI: 148638001000

VAT: EL801081551

Telephone: +30 210 6390267

Email: [email protected]

Website: https://curitypharma.com